pazopanib
PolandDrugs containing this active substance
-
It is used in adults for the treatment of advanced renal cell carcinoma (with metastases to other organs) and in certain types of soft tissue sarcoma.
Form: tablets, film-coated
Active substance Dosage pazopanib 200 mg ATC: L01EX03
Manufacturer: PharOS Mt Ltd
-
The medicine is used in adult patients for the treatment of advanced renal cell carcinoma (with metastases to other organs) and certain types of soft tissue sarcoma.
Form: tablets, film-coated
Active substance Dosage pazopanib 400 mg ATC: L01EX03
Manufacturer: PharOS Mt Ltd
-
The medicine is used in adults for the treatment of advanced or metastatic renal cell carcinoma and in certain types of soft tissue sarcoma.
Form: tablets, film-coated
Active substance Dosage pazopanib 200 mg ATC: L01EX03
Manufacturer: PharOS Mt Remedica Ltd
-
The medicine is used in adults for the treatment of advanced or metastatic renal cell carcinoma and in certain types of soft tissue sarcoma.
Form: tablets, film-coated
Active substance Dosage pazopanib 400 mg ATC: L01EX03
Manufacturer: PharOS Mt Remedica Limited
-
The medicine is used in adult patients for the treatment of advanced renal cell carcinoma (with metastases to other organs) and for the treatment of certain types of soft tissue sarcoma.
Form: tablets, film-coated
Active substance Dosage pazopanib 200 mg ATC: L01EX03
Manufacturer: Logiters Logistica Portugal S.A. Mylan Germany GmbH PharOS Mt Ltd Pharos Pharmaceutical Oriented Services Ltd. Remedica Ltd
-
The medicine is used in adult patients for the treatment of advanced renal cell carcinoma (with metastases to other organs) and for the treatment of certain types of soft tissue sarcoma.
Form: tablets, film-coated
Active substance Dosage pazopanib 400 mg ATC: L01EX03
Manufacturer: Logiters Logistica Portugal S.A. Mylan Germany GmbH PharOS Mt Ltd Pharos Pharmaceutical Oriented Services Ltd. Remedica Ltd